查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1471966

連續血糖監測設備市場規模和預測、全球和區域佔有率、趨勢和成長機會分析（按產品、應用、測試地點、最終用戶和地理位置）

Continuous Glucose Monitoring Device Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis By Product, Application, Testing Site, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

連續血糖監測設備 (CGMD) 市場規模預計將從 2022 年的 98 億美元成長到 2030 年的 285 億美元。傑出參與者。

連續監測對糖尿病管理的高度重要性支撐了連續血糖監測設備的市場規模

目前，糖尿病的管理極為複雜，因為這種疾病會導致人們形成新的生活習慣、藥物治療等。此外，患有糖尿病的人需要仔細監測血糖值。由於難以維持高血糖水平，糖尿病患者對連續血糖監測設備的需求很高。這些設備是最先進的技術設備，透過感測器、發射器和監視器等組件重塑了手動糖尿病管理。憑藉其智慧功能，連續血糖監測設備為糖尿病患者提供有關血糖水平的即時更新，這有助於他們按照醫療保健醫生的指示調整飲食模式或胰島素劑量。這種即時更新降低了糖尿病患者發生低血糖或高血糖的風險。此外，近年來醫療設備產業的顯著擴張，主要是在 COVID-19 大流行期間，對連續血糖監測設備的市場規模產生了積極影響。連續血糖監測設備技術的進步使糖尿病患者的生活變得更加輕鬆。例如，胰島素管理和血糖監測已經從每天多次手指刺穿轉變為在手機上滑動幾次。

科技趨勢

科技在糖尿病照護中發揮著至關重要的作用，因為現代技術支援各種設備和工具。連續血糖監測設備製造商瞄準的是低收入和中等收入(LMIC) 市場，而不是高收入市場，因為他們預計這些國家的糖尿病患者會轉而使用連續血糖監測設備產品，特別是如果他們能夠獲得這些設備的良好報銷的話。此外，持續監測而不是重複的自我監測有助於進一步緩解壓力。與自動治療輸送系統（例如胰島素幫浦）整合的連續血糖監測設備可以為無需根據連續血糖監測設備讀數手動調整胰島素劑量的個人帶來好處。因此，連續血糖監測設備的進步可能會在未來幾年帶來新的連續血糖監測設備市場趨勢。

連續血糖監測設備市場（按產品）：

依產品分類，市場分為感測器、發射器和接收器。到 2022 年，感測器細分市場將佔據最大的連續血糖監測設備市場。 2024年1月，Dexcom宣布向美國食品藥物管理局（FDA）提交名為「Stelo Glucose Sensor」的新型葡萄糖感測器的批准。這種新型感測器特別適用於為 2 型糖尿病患者設計的設備，幫助他們透過維持飲食、運動、睡眠和壓力來監測健康狀況。根據《中低收入國家的自我監測設備》報告，主要連續血糖監測設備供應商（雅培、Dexcom 和美敦力）的收入主要由感測器驅動。此外，患者經常喜歡使用感測器（平均每 10-14 天一次）。因此，感測器佔連續血糖監測設備市場總銷售收入的60-90%。

區域分析

全球連續血糖監測設備市場報告按地理位置分類為北美、歐洲、亞太地區、南美和中美洲以及中東和非洲。 2022年，北美佔據最大的連續血糖監測設備市場。該地區的市場成長是由頂級公司推出的產品數量不斷增加以及主要市場參與者的存在所推動的。

產業發展及未來機會：

以下列出了連續血糖監測設備市場領導者的一些策略發展：

2023 年 10 月，Philips-Medisize 宣布與 GlucoModicm 合作，將專有的非侵入性穿戴裝置商業化。此次合作旨在為尋求更好監測血糖水平的糖尿病患者打造無針、準確且更實惠的解決方案。

競爭格局及重點企業：

B. Braun SE、F. Hoffmann-La-Roche Ltd、LifeScan Inc、Medtronic、Abbott Laboratories、Ypsomed Holding AG、Sensionics、Nipro Corp、GE Healthcare 和 Terumo Corp 是連續血糖監測設備市場報告中的知名公司。這些公司專注於新技術、升級現有產品和地理擴張，以滿足全球不斷成長的消費者需求。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解
  • 市場吸引力分析

第 3 章：研究方法

第 4 章：連續血糖監測設備市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈供應商名單

第 5 章：連續血糖監測設備市場 - 主要市場動態

  • 主要市場促進因素
  • 主要市場限制
  • 主要市場機會
  • 未來的趨勢
  • 促進因素和限制因素的影響分析

第 6 章：連續血糖監測設備市場 - 全球市場分析

  • 連續血糖監測設備 - 全球市場概覽
  • 連續血糖監測設備 - 全球市場與 2031 年預測

第 7 章：連續血糖監測設備市場 - 收入分析 - 按產品，2021-2031 年

  • 概述
  • 感應器
  • 發射機
  • 接收器

第 8 章：連續血糖監測設備市場 - 收入分析 - 按應用，2021-2031 年

  • 概述
  • 1 型糖尿病
  • 2型糖尿病

第 9 章：連續血糖監測設備市場 - 收入分析 - 按測試站點，2021-2031 年

  • 概述
  • 指尖測試
  • 備用站點測試

第 10 章：連續血糖監測設備市場 - 收入分析 - 按最終用戶，2021-2031 年

  • 概述
  • 醫院和診所
  • 自我/家庭護理

第 11 章：連續血糖監測設備市場 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

註 - 將為以下提到的地區/國家提供類似的分析

  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第13章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與專注

第 14 章：連續血糖監測設備市場 - 主要公司簡介

  • B. Braun SE
  • F. Hoffmann-La-Roche Ltd
  • LifeScan Inc
  • Medtronic
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Sensionics
  • Nipro Corp
  • GE Healthcare
  • Terumo Corp

第 15 章：附錄

簡介目錄
Product Code: TIPRE00018031

The Continuous Glucose Monitoring Devices (CGMD) market size is expected to grow from US$ 9.8 billion in 2022 to US$ 28.5 billion by 2030. The Continuous Glucose Monitoring Device market report emphasizes key factors driving the Continuous Glucose Monitoring Device market growth and developments by prominent players in the market.

High Importance of Continuous Monitoring for Diabetes Management Bolsters Continuous Glucose Monitoring Device Market Size

Currently, diabetes management is extremely complex, as the disease results in people creating new lifestyle habits, medications, and so on. Moreover, people suffering from diabetes require careful monitoring of blood glucose levels. The demand for Continuous Glucose Monitoring Devices is high among diabetic people owing to the high glucose levels that are difficult to maintain. These devices are the most advanced technology devices that have reshaped manual diabetes management with their components, such as sensors, transmitters, and monitors. With their smart features, Continuous Glucose Monitoring Devices provide people with diabetes real-time updates regarding blood sugar levels, which helps them modify dietary patterns or insulin doses as directed by the healthcare physician. Such real-time updates reduce the risk of hypoglycemia or hyperglycemia among people living with diabetes. Further, significant expansion of the medical device industry in recent years, primarily during the COVID-19 pandemic, has positively impacted the Continuous Glucose Monitoring Device market size. Advancements in Continuous Glucose Monitoring Device technologies have made life easier for people with diabetes. For example, insulin administration and blood glucose monitoring have transformed from multiple finger pricks daily to a few swipes on a cell phone.

Technological Trends

Technology plays a vital role in diabetes care, as a wide range of devices and tools are enabled with modern technologies. Continuous Glucose Monitoring Device manufacturers target low- and middle-income (LMIC) markets rather than high-income markets, as they anticipate that diabetic people from these countries would switch to Continuous Glucose Monitoring Device products, particularly if they are reimbursed well for these devices. Moreover, continuous monitoring instead of repetitive self-monitoring aids in additional relief. Continuous Glucose Monitoring Devices integrated with automated treatment delivery systems (e.g., insulin pumps) can offer benefits to individuals who don't have to manually adjust insulin dosages based on Continuous Glucose Monitoring Device readings. Thus, advancements in Continuous Glucose Monitoring Devices are likely to bring new Continuous Glucose Monitoring Device market trends in the coming years.

Continuous Glucose Monitoring Devices Market, by Product:

By product, the market is segmented into sensors, transmitters, and receivers. The sensors segment held the largest Continuous Glucose Monitoring Device market share in 2022. The same segment is anticipated to register the highest CAGR of 14.6% during the forecast period. In January 2024, Dexcom announced the submission of approval for a new glucose sensor named "Stelo Glucose Sensor" to the Food and Drug Administration (FDA). The new sensor is indicated particularly for devices designed for people suffering from type 2 diabetes to help them monitor health through maintaining diet, exercise, sleep, and stress. According to the "Self-Monitoring Devices in LMICs" report, the revenue for major Continuous Glucose Monitoring Device suppliers (Abbott, Dexcom, and Medtronic) is driven primarily by sensors. Also, patients prefer sensors frequently (every 10-14 days on average). Thus, sensors account for 60-90% of the total sales revenue in the Continuous Glucose Monitoring Device market.

Regional Analysis

The global Continuous Glucose Monitoring Device market report is geographically segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest Continuous Glucose Monitoring Device market share. The market growth in this region is driven by the increasing number of product launches by top companies and the presence of key market players.

Industry Developments and Future Opportunities:

A few strategic developments by leading players operating in the Continuous Glucose Monitoring Device market are listed below:

In October 2023, Philips-Medisize announced a partnership with GlucoModicm to commercialize a proprietary noninvasive and wearable device. The partnership is aimed to create a solution that is needle-free, accurate, and more affordable for diabetic people seeking ways to monitor blood glucose levels better.

Competitive Landscape and Key Companies:

B. Braun SE, F. Hoffmann-La-Roche Ltd, LifeScan Inc, Medtronic, Abbott Laboratories, Ypsomed Holding AG, Sensionics, Nipro Corp, GE Healthcare, and Terumo Corp are the prominent companies in the Continuous Glucose Monitoring Device market report. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the growing consumer demand worldwide.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Continuous Glucose Monitoring Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Continuous Glucose Monitoring Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Continuous Glucose Monitoring Devices Market - Global Market Analysis

  • 6.1 Continuous Glucose Monitoring Devices - Global Market Overview
  • 6.2 Continuous Glucose Monitoring Devices - Global Market and Forecast to 2031

7. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By Product, 2021-2031

  • 7.1 Overview
  • 7.2 Sensors
  • 7.3 Transmitters
  • 7.4 Receivers

8. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 8.1 Overview
  • 8.2 Type 1 Diabetes
  • 8.3 Type 2 Diabetes

9. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By Testing Sites, 2021-2031

  • 9.1 Overview
  • 9.2 Fingertip Testing
  • 9.3 Alternate Site Testing

10. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 10.1 Overview
  • 10.2 Hospitals and Clinics
  • 10.3 Self/Homecare

11. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Continuous Glucose Monitoring Devices Market Overview
    • 11.1.2 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts to 2031
    • 11.1.3 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Product
    • 11.1.4 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Application
    • 11.1.5 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Testing Sites
    • 11.1.6 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Continuous Glucose Monitoring Devices Market
        • 11.1.7.1.1 United States Continuous Glucose Monitoring Devices Market, by Product
        • 11.1.7.1.2 United States Continuous Glucose Monitoring Devices Market, by Application
        • 11.1.7.1.3 United States Continuous Glucose Monitoring Devices Market, by Testing Sites
        • 11.1.7.1.4 United States Continuous Glucose Monitoring Devices Market, by End User
      • 11.1.7.2 Canada Continuous Glucose Monitoring Devices Market
        • 11.1.7.2.1 Canada Continuous Glucose Monitoring Devices Market, by Product
        • 11.1.7.2.2 Canada Continuous Glucose Monitoring Devices Market, by Application
        • 11.1.7.2.3 Canada Continuous Glucose Monitoring Devices Market, by Testing Sites
        • 11.1.7.2.4 Canada Continuous Glucose Monitoring Devices Market, by End User
      • 11.1.7.3 Mexico Continuous Glucose Monitoring Devices Market
        • 11.1.7.3.1 Mexico Continuous Glucose Monitoring Devices Market, by Product
        • 11.1.7.3.2 Mexico Continuous Glucose Monitoring Devices Market, by Application
        • 11.1.7.3.3 Mexico Continuous Glucose Monitoring Devices Market, by Testing Sites
        • 11.1.7.3.4 Mexico Continuous Glucose Monitoring Devices Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Continuous Glucose Monitoring Devices Market - Key Company Profiles

  • 14.1 B. Braun SE
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 14.2 F. Hoffmann-La-Roche Ltd
  • 14.3 LifeScan Inc
  • 14.4 Medtronic
  • 14.5 Abbott Laboratories
  • 14.6 Ypsomed Holding AG
  • 14.7 Sensionics
  • 14.8 Nipro Corp
  • 14.9 GE Healthcare
  • 14.10 Terumo Corp

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud